Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2007-01-30
2007-01-30
Nazario-Gonzalez, Porfirio (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C560S061000, C562S621000
Reexamination Certificate
active
10311756
ABSTRACT:
Formula (I) compounds are described, where the groups are defined in the description, as well as processes for their preparation and their use as medicaments, particularly as selective phosphodiesterase IV inhibitors.
REFERENCES:
patent: 3714356 (1973-01-01), Burrous et al.
patent: 4335054 (1982-06-01), Blaser et al.
patent: 4820828 (1989-04-01), Demers et al.
patent: 4971959 (1990-11-01), Hawkins
patent: 6235739 (2001-05-01), Ina et al.
patent: 0 511 865 (1992-11-01), None
patent: 0 933 366 (1999-08-01), None
patent: 92 00968 (1992-01-01), None
patent: 92 19594 (1992-11-01), None
patent: 95 08534 (1995-03-01), None
patent: 97 05098 (1997-02-01), None
patent: 97 05105 (1997-02-01), None
patent: 99 05143 (1999-02-01), None
patent: 99 15494 (1999-04-01), None
patent: WO 99/15494 (1999-04-01), None
patent: 99 30709 (1999-06-01), None
patent: WO 00/35915 (2000-06-01), None
patent: 01 32649 (2001-05-01), None
Budavari, The Merck Index, 12th Edition, p. 267.
Yamamoto et al, Chemical & Pharmaceutical Bulletin, 1982, vol. 30 (10), pp. 3601-3616.
Rao et al, Current Science, 1969, 38(4), pp. 90-91.
Search Report and International Preliminary Examination Report for PCT IT 01/312.
CA 116:202019 abstract for Farkas et al, Journal of Coordination Chemistry, 24 (4) pp. 325-332 (1991).
Nicholson et al., Pulmonary Pharmacology, vol. 7, No. 1, pp. 1-17 (1994).
Banner et al., European Respiratory Journal, vol. 8, pp. 996-1000 (1995).
Badger et al, “Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifyline, and rolipram in a murine model of endotoxin shock”, Circ Shock, Dec. 1994; 44(4):188-95.
S. Budavari (Ed): “The Merk Index (12thedition)”, Merck & Co, Whitehouse Station, NJ XP002184331 p. 267, paragraph 1673-p. 268 (1996).
S. Budavari (Ed): “The Merk Index (12thedition)”, Merck & Co, Whitehouse Station, NJ XP002184332 p. 933, paragraph 5490-p. 934 (1996).
S. Budavari (Ed): “The Merk Index (12thedition)”, Merck & Co, Whitehouse Station, NJ XP002184333 p. 1034, paragraph 6133 (1996).
Buu-Hoi, N. P. et el: “Synthesis and pharmacological properties of substituted cinnamohydroxamic acids” J. Med. Chem. (1970), 13(2), 211-13, 1970, XP002184329 p. 212; examples 9-11, 14-16, 19-21, 28, 29, 31-33; table 1.
Hebel, David et al: “Selective monoflurination of biologically interesting compounds using acetyl hypolluorite” Bull, Soc. Chim. Fr. (1986), (6), 861-3, 1986, XP002184330, p. 861; figure 5, p. 863, paragraph 2.
Fanto′ Nicola
Tinti Maria Ornella
Nazario-Gonzalez Porfirio
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
Compounds useful for the preparation of medicaments with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds useful for the preparation of medicaments with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds useful for the preparation of medicaments with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3749766